All In Biotech

Drug Trial Radar · NCT04039022

Open-Label Safety Study of AXS-05 in Subjects With Depression

An Open-Label Study to Assess the Long-term Safety and Efficacy of AXS-05 in Subjects With Major Depressive Disorder

Last checked: Nov 19, 2026Latest source record: Oct 12, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

876

Actual

Start

Jul 8, 2019

Primary completion

Oct 23, 2020

Study completion Oct 23, 2020

Sponsor

Lead sponsor
Axsome Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Jul 31, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

An open-label, long-term, safety study of AXS-05 in patients with major depressive disorder (MDD), including treatment resistant depression.

Conditions

  • Major Depressive Disorder
  • Treatment Resistant Depression
  • Depression

Interventions

  • AXS-05 (dextromethorphan and bupropion) oral tabletsDrug

    Oral tablets, taken twice daily for up to 12 months.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-emergent AEs (TEAEs) Following Dosing With AXS-05Time frame: Up to 12 months

Locations

51 sites in 1 country. Site status is shown where the registry gives one.

  • Clinical Research Site

    Phoenix, Arizona

  • Clinical Research Site

    Little Rock, Arkansas

  • Clinical Research Site

    Bellflower, California

  • Clinical Research Site

    Beverly Hills, California

  • Clinical Research Site

    Culver City, California

  • Clinical Research Site

    Garden Grove, California

  • Clinical Research Site

    Oakland, California

  • Clinical Research Site

    Oceanside, California

  • Clinical Research Site

    Panorama City, California

  • Clinical Research Site

    Redlands, California

  • Clinical Research Site

    San Diego, California

  • Clinical Research Site

    Sherman Oaks, California

  • Clinical Research Site

    Upland, California

  • Clinical Research Site

    Cromwell, Connecticut

  • Clinical Research Site

    Coral Springs, Florida

  • Clinical Research Site

    Hialeah, Florida

  • Clinical Research Site

    Hollywood, Florida

  • Clinical Research Site

    Jacksonville, Florida

  • Clinical Research Site

    Lauderhill, Florida

  • Clinical Research Site

    Miami, Florida

  • Clinical Research Site

    North Miami, Florida

  • Clinical Research Site

    Orlando, Florida

  • Clinical Research Site

    Atlanta, Georgia

  • Clinical Research Site

    Atlanta, Georgia

  • Clinical Research Site

    Boise, Idaho

  • Clinical Research Site

    Chicago, Illinois

  • Clinical Research Site

    Boston, Massachusetts

  • Clinical Research Site

    Las Vegas, Nevada

  • Clinical Research Site

    Berlin, New Jersey

  • Clinical Research Site

    Cherry Hill, New Jersey

  • Clinical Research Site

    Toms River, New Jersey

  • Clinical Research Site

    Jamaica, New York

  • Clinical Research Site

    Rochester, New York

  • Clinical Research Site

    Staten Island, New York

  • Clinical Research Site

    Hickory, North Carolina

  • Clinical Research Site

    Raleigh, North Carolina

  • Clinical Research Site

    Cincinnati, Ohio

  • Clinical Research Site

    Cincinnati, Ohio

  • Clinical Research Site

    Middleburg Heights, Ohio

  • Clinical Research Site

    Oklahoma City, Oklahoma

Showing 40 of 51 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.